Business Context and Reporting Period
This Form 8-K, filed on April 24, 2017, reports events occurring on April 23, 2017, for Becton, Dickinson and Company (BD). The primary event is the entry into a definitive Agreement and Plan of Merger with C.R. Bard, Inc. (Bard), under which BD will acquire Bard. Additionally, the filing reports the election of a new President and amendments to BD's By-Laws.
Key Financial Metrics and Transaction Terms
The filing details the financial structure of the proposed merger but does not report BD's standalone operating results (revenue, profit, cash flow) for a specific period.
- Merger Consideration: Bard shareholders will receive $222.93 in cash and 0.5077 shares of BD common stock for each Bard share.
- Stock Consideration Cap: If the stock issuance would exceed 19.9% of BD's outstanding shares, the stock portion will be reduced and the cash portion increased accordingly.
- Financing: BD has secured a $15.7 billion unsecured 364-day bridge loan facility to fund the cash consideration.
- Termination Fee: Bard is required to pay BD a $750 million fee if Bard terminates the agreement to accept a superior proposal or changes its recommendation.
Material Changes and Corporate Actions
The filing outlines significant structural and governance changes effective April 23, 2017:
- Leadership Change: Thomas E. Polen was elected President of BD. Vincent A. Forlenza, previously Chairman, CEO, and President, will continue as Chairman and CEO.
- By-Law Amendment: BD amended its By-Laws to remove prohibitions on board committees declaring dividends or issuing additional shares of authorized capital stock.
- Board Composition: Upon closing, the Bard Chairman and an independent Bard director will join the BD board.
Outlook, Risks, and Contingencies
Completion of the merger is subject to several material conditions and risks:
- Closing Conditions: Requires Bard stockholder approval, SEC effectiveness of the Form S-4 registration statement, NYSE listing approval, and antitrust approvals in the U.S. and other jurisdictions.
- Forward-Looking Risks: Management highlights risks regarding integration, realization of synergies, regulatory approvals for Bard products, potential litigation, and fluctuations in interest or foreign currency rates.
- Financing Contingency: The bridge loan funding is contingent on the execution of definitive documentation and the consummation of the merger.
Investor Verification Checklist
- Verify the final terms of the Merger Agreement in the Form S-4 proxy statement/prospectus when filed.
- Monitor the status of antitrust approvals and Bard stockholder vote results.
- Review the $15.7 billion bridge loan commitment letter for specific covenants and interest rate terms.
- Assess the impact of the 19.9% stock issuance cap on the final cash/stock mix of the deal.
- Confirm the timeline for the integration of Bard's operations and the realization of projected synergies.